Explore evidence

Gold tier: mechanically validated evidence, with its primary source.

2,235 evidence items · page 79 / 90

117 participantsQuantitative stigma scores among the 117 participants were similar for HIV-related (Median: 28.00; IQR: 28.0, 34.0), cancer-related (Median: 28.0; IQR: 28.0, 34.8), and skin disease-related stigma (Median: 28.0; IQR: 27.0, 34.0).

Kenyacancer (non précisé) · skin disease · VIH/sidapublished 2022Journal of the International AIDS SocietyPubMeddocument of 4 observations

72.7 %Among AYPLHIV aged 10–24 enrolled in Operation Triple Zero (OTZ) from 2017 to 2021, viral load suppression (VLS) improved from 72.7% to 88.5%.

KenyaVIH/sidaobserved 2017 to 2021published 2025The Journal of adolescent health : official publication of the Society for Adolescent MediPubMeddocument of 9 observations

6 deathsSix of seven deaths within 90 days of NTS bacteremia had HIV/AIDS as the primary cause of death assigned on verbal autopsy in the rural site in Kenya from 2006 to 2009.

Kenyanon-Typhi Salmonella · VIH/sidaobserved 2006-2009published 2012PloS oneeurope_pmcdocument of 9 observationsDOI 10.1371/journal.pone.0031237

0.329 odds_ratioThe odds of being virally suppressed were reduced by TGF-β (OR = 0.329, 95% CI: 0.035–0.361) in HIV-1 participants on first-line cART.

KenyaVIH/sidapublished 2025The Pan African medical journalPubMeddocument of 11 observations

1.65 prevalence_ratioAmong female patients under 20 years living with HIV in Western Kenya, violence was associated with stigma with a prevalence ratio of 1.65.

Kenyastigma · VIH/sidapublished 2026The Journal of the Association of Nurses in AIDS Care : JANACPubMeddocument of 8 observations

28.6 %From December 2021 to May 2023, 114 out of 398 participants (28.6%) had never heard of HIV post-exposure prophylaxis (PEP).

KenyaVIH/sidaobserved December 2021 to May 2023published 2025Journal of the International AIDS SocietyPubMeddocument of 7 observations

5,115 infantsOf 9539 infants tested for HIV, 5115 received laboratory-based early infant diagnosis.

KenyaVIH/sidapublished 2020Journal of acquired immune deficiency syndromes (1999)PubMeddocument of 13 observations

43.9 %The condom programme for men who have sex with men had utilization coverage of 43.9%.

KenyaVIH/sidaobserved 2023published 2024Journal of the International AIDS SocietyPubMeddocument of 10 observations

46.7 %Among men who have sex with men living with HIV in Kenya, 46.7% of those who solely met partners via physical sites (PMSM) were diagnosed and aware of their status.

KenyaVIH/sidaobserved 2019published 2020Journal of the International AIDS SocietyPubMeddocument of 12 observations

23.8 %Among 623 people who inject drugs living with HIV (PWID-LH) and their partners on antiretroviral therapy (ART) for ≥4 months in Kenya, 148 (23.8%) were not virally suppressed.

KenyaVIH/sidapublished 2024AIDS research and human retrovirusesPubMeddocument of 3 observations

0.42 aHRFormal employment was negatively associated with poor outcomes (adjusted hazard ratio = 0.42, 95%CI 0.23–0.76).

KenyaVIH/sidapublished 2022PloS onePubMeddocument of 15 observations

1.4 %At baseline, harmful alcohol use (AUDIT 16-19) was present in 1.4% of HIV-positive female sex workers in Mombasa, Kenya.

KenyaVIH/sidapublished 2020PloS onePubMeddocument of 6 observations

445 deathsA total of 445 female sex workers died from HIV/AIDS among those reported by 853 female sex workers in Kenya, Nigeria, and the Democratic Republic of the Congo.

Kenya · Nigeria · RDCVIH/sidaobserved 2022-02-01 to 2023-02-28published 2026International journal of environmental research and public healthPubMeddocument of 10 observations

0.25 adjusted_hazard_ratioAccessing needle and syringe programmes was associated with lower HIV incidence (adjusted hazard ratio = 0.25; 95% CI: 0.087–0.58).

KenyaVIH/sidapublished 2025The International journal on drug policyPubMeddocument of 10 observations

33.3 per_100One in three widows living with HIV may have acquired the virus during widowhood.

KenyaVIH/sidapublished 2026Global health actioneurope_pmcdocument of 5 observations

1.05 prevalence_ratioNewly-diagnosed HIV prevalence showed no observed sex difference, with a prevalence ratio of 1.05 (95% CI 0.65–1.69).

KenyaVIH/sidapublished 2024PloS onePubMeddocument of 6 observations

1.45 relative riskThe strongest predictor of latent class membership was age (RR 1.45; 95% CI: 1.08–1.95; p = 0.006).

KenyaVIH/sidapublished 2022Journal of the International AIDS SocietyPubMeddocument of 2 observations

Increases in Tumor necrosis factor-alpha (TNF-α) levels without corresponding increase in Interleukin-6 (IL-6) levels were observed in HIV infected patients.

KenyaVIH/sidapublished 2017Kenyatta University Institutional Repository (Kenyatta University)OpenAlexdocument of 7 observations

18.59 %The unadjusted HIV prevalence among people who inject drugs (PWIDs) in the Coastal region was 18.59%.

KenyaVIH/sidapublished 2021BMC public healthPubMeddocument of 17 observations

10.75 USD_per_client_monthThe estimated economic cost per client-month on PEP was $10.75 USD for non-subsidized delivery.

KenyaVIH/sidapublished 2025BMC health services researchPubMeddocument of 13 observations

2 foldA dynamic choice HIV prevention intervention resulted in two-fold greater time covered by biomedical prevention products compared to standard-of-care in general outpatient departments in eastern Africa.

KenyaVIH/sidapublished 2024AIDS (London, England)PubMeddocument of 18 observations

0.76 odds_ratioThe intervention had no effect on low mid-upper arm circumference, with an odds ratio of 0.76 [95% confidence interval (CI) 0.39, 1.45].

KenyaVIH/sidapublished 2025AIDS (London, England)PubMed

23.8 %HIV seroprevalence among partners of HIV-positive persons who inject drugs was 23.8% on the Coast and 17.1% in Nairobi.

KenyaVIH/sidapublished 2022BMC infectious diseasesPubMeddocument of 4 observations

Among PLHIV, viral load ≥1000 copies/mL was associated with higher TNF-α levels.

KenyaVIH/sidapublished 2021Clinical infectious diseases : an official publication of the Infectious Diseases Society PubMeddocument of 8 observations

33.8 hoursIn scenario 2, the average turnaround time (TAT) for HIV viral load monitoring decreased to 33.8 hours.

KenyaVIH/sidapublished 2024Health policy and planningPubMeddocument of 15 observations

Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.